Flo Health, a London, UK-based women’s health app provider, raised more than $200M in Series C funding.
The investment, which brought Flo’s valuation beyond $1 billion, was made by General Atlantic. As part of the transaction, Tanzeen Syed, Managing Director and Head of Consumer Internet and Technology at General Atlantic, and Jessie Cai, will join Flo’s Board of Directors.
Led by Dmitry Gurski, co-founder and CEO, and Anna Klepchukova, Chief Medical Officer, Flo Health aims to support women at every stage of their health journey, from menstruation to conception, pregnancy, and menopause. With over 120 doctors and health experts, the platform offers curated cycle and ovulation tracking. Users can monitor over 70 symptoms and access various features designed to enhance their understanding and management of their health. Flo also provides users with tailored health insights, expert tips, daily bite-sized visual content, and access to a private digital discussion community focused on health and wellness-related topics. In 2023, Flo launched ‘Flo for Partners’, which enables users to educate and empower their partners with scientific insights into their menstrual and reproductive health.
Flo’s partnership with General Atlantic will help position the company for its next phase of growth, with a focus on expanding into new user segments including perimenopause and menopause, enhancing its tech-driven health insights, and pursuing strategic expansion opportunities. To support these goals, Flo intends to increase R&D headcount with investments in talent across its global offices in Europe and North America. Flo also intends to leverage General Atlantic’s expertise in scaling companies at the intersection of consumer technology, healthcare, and subscription business models.
As of June 2024, the company supports nearly 70 million monthly active users (MAUs) and close to 5 million paid subscribers. Gross bookings for 2024 are expected to exceed $200 million this year.
FinSMEs
30/07/2024